parameters | survivors | non-survivors | P-value |
---|---|---|---|
N (%) | 289 (81.4) | 66 (18.6) | - |
Age (year) | 65.2 ± 11.1 | 71.7 ± 8.7 | < 0.001 |
Gender (M/F) | 113/176 (39.1/60.1) | 36/30(54.5/45.5) | 0.02 |
Hospital stay (days) | 11.6 ± 7.1 | 5.7 ± 4.4 | < 0.001 |
ALT (U/L) | 71.7 (44.4, 135) | 122.9 (57.3, 224.8) | < 0.001 |
AST (U/L) | 136 (74.2, 266.2) | 371.3 (209.0, 750.7) | < 0.001 |
AST/ALT ratio | 1.94 (1.4, 2.56) | 3.52 (2.52, 4.54) | < 0.001 |
GGT (U/L) | 31 (18, 58) | 52 (23, 139.3) | < 0.001 |
ALP (U/L) | 64 (51, 80) | 78 (58.2, 158.5) | < 0.001 |
mAST (U/L) | 34.3 (19.4, 68.7) | 92.7 (55.2, 155.7) | < 0.001 |
mAST/AST ratio | 0.242 (0.210, 0.258) | 0.254 (0.245, 0.26) | < 0.001 |
mAST/ALT ratio | 0.49 (0.35, 0.63) | 0.77 (0.59, 1.02) | < 0.001 |
cAST (U/L) | 101.4 (55.9, 194.8) | 278.6 (153.8, 594.4) | < 0.001 |
cAST/ALT ratio | 1.45 (1.05, 1.90) | 2.72 (1.97, 3.45) | < 0.001 |
hsTnI (pg/ml) | 50 (26, 107) | 253.5 (75.5, 1539.5) | < 0.001 |
CK (U/L) | 333 (125, 906) | 1035 (435.5, 2597.3) | < 0.001 |
CK-MB (ng/ml) | 3.63 (2.25, 7.14) | 7.50 (4.39, 17.79) | < 0.001 |
α-HBDH (U/L) | 351.0 (249.0, 537.8) | 846.0 (552.4, 1439.3) | < 0.001 |
LDH (U/L) | 538 (375, 846) | 1422.5 (869.3, 2567.5) | < 0.001 |